A California biotech company says its experimental drug remdesivir improved symptoms when given for five days to moderately ill, hospitalized patients with COVID-19.
South Africa says it has a backlog of nearly 100,000 unprocessed tests for the coronavirus, a striking example of the painful shortage of testing kits and reagents across Africa as cases steadily rise.
Katherine West writes on the current HIV science and the significant changes in post-exposure testing and medical follow up.
A top health expert is warning that the world is still smack in the middle of the pandemic, dampening hopes for a speedy global economic rebound and renewed international travel.
The Trump administration’s new strategy for coronavirus testing puts much of the burden on states while promising to provide supplies such as swabs and material to transport specimens.
Thousands of “gig economy” workers, including ride-hailing service drivers and food couriers, are torn between safety and sustenance.
Public health officials in some states are accused of bungling coronavirus infection statistics or even using a little sleight of hand to deliberately make things look better than they are.
The new at-home option is expected to expand use of the test developed by Rutgers University, which the Food and Drug Administration first authorized last month.
U.S. regulators Monday pulled back a decision that allowed scores of coronavirus blood tests to hit the market without first providing proof that they worked.
In the interest of transparency and sharing knowledge, here is information about the National Registry examinations – backed by science, not myths and misinformation.